Biotech Deals refer to agreements or contracts made within the biotechnology sector that involve the commercial exchange of goods, services, technologies, or intellectual property. These deals can include mergers and acquisitions, partnership agreements, licensing agreements, joint ventures, and collaborations between biotech companies, pharmaceutical firms, research institutions, or investors. The primary focus is on the development, production, and commercialization of biotechnological innovations and products, including drugs, therapies, and diagnostic tools. Biotech deals are often significant for advancing scientific research and can play a crucial role in bringing new healthcare solutions to market.
**Investment firm RTW Investments has launched a cutting-edge biotech venture named Prolium Bioscience, aimed at revolutionizing treatment for certain cancers.** With a strategic focus on a promising CD20×CD3 bispecific antibody,…